NASDAQ · Biotechnology

ARS Pharmaceuticals, Inc. (SPRY) Stock

$4.29 -6.03% NASDAQ: SPRY Healthcare

Valuation

MetricValue
Price$4.29
Market Cap$425.51M
P/E Ratio-1.97
P/B Ratio34.05
P/S Ratio3.64
EPS (TTM)$-1.74
52-Week High$13.15
52-Week Low$3.98
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-256.67%
ROA-86.35%
ROCE-114.65%
Gross Margin77.10%
Operating Margin-2.04%
Net Margin-184.24%
Debt/Equity13.72
Current Ratio7.31

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.0M$1.0M$0$89.0M$84.0M
Operating Profit$-19.0M$-36.0M$-68.0M$-3.0M$-179.0M
Net Profit$-20.0M$-35.0M$-54.0M$8.0M$-171.0M
EPS$-0.70$-0.87$-0.57$0.08$-1.74
Op Margin-353.3%-2698.8%-225066.7%-3.5%-212.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$61.0M$281.0M$233.0M$351.0M$328.0M
Total Liabilities$93.0M$9.0M$2.0M$94.0M$213.0M
Cash$60.0M$211.0M$71.0M$51.0M$41.0M
Borrowings$9.0M$0$0$0$96.0M

Latest News

ARS Pharmaceuticals (SPRY) Appoints Donn Casale As The New CEO Insider Monkey · Jul 15, 2026 Strength Seen in CRINETICS PHARM (CRNX): Can Its 98.7% Jump Turn into More Strength? Zacks · Jul 8, 2026 ARS Pharmaceuticals Names Donn Casale as CEO as Richard Lowenthal Departs MT Newswires · Jul 7, 2026 ARS Pharmaceuticals Announces CEO Succession GlobeNewswire · Jul 7, 2026 ARS Pharmaceuticals (SPRY) Is Down 11.5% After Losing Spots in Key Russell 2000 Defensive Indices Simply Wall St. · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-18.0M$-40.0M$-59.0M$14.0M$-171.0M
Investing Cash Flow$0$0$-87.0M$-107.0M$56.0M
Financing Cash Flow$0$199.0M$0$0$3.0M
Net Cash Flow$36.0M$150.0M$-140.0M$-20.0M$-9.0M
Free Cash Flow$-18.0M$-40.0M$-59.0M$13.0M$-171.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.02
EV / EBITDA-2.85
FCF Yield-46.15%
Quick Ratio3.28
Interest Coverage-43.96
Return 1Y-66.67%
Return 3Y-18.48%
Return 5Y-74.64%

Ownership

Insiders Held16.21%
Institutions Held94.46%
Institutions Float Held112.74%
Institutional HolderSharesReport Date
RA Capital Management, L.P.10,860,9772026-03-31
Orbimed Advisors LLC.8,288,5102026-03-31
Rubric Capital Management LP8,000,0002026-03-31
Deerfield Management Company, L.P7,503,8122026-03-31
Millennium Management Llc5,982,9192026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc. is led by CEO Richard E. Lowenthal, employs 155 people, headquartered in US, publicly traded since 2020.

ARS Pharmaceuticals, Inc. (SPRY) stock trades at $4.29 with a market capitalization of $425.51M. The stock is valued at a price-to-earnings (P/E) ratio of -1.97, price-to-book of 34.05, price-to-sales of 3.64. Over the past 52 weeks the stock has ranged between $3.98 and $13.15, and currently trades 67.4% below its 52-week high.

On profitability, ARS Pharmaceuticals, Inc. generates a return on equity (ROE) of -256.67%, return on capital employed of -114.65%, an operating margin of -2.04%, a net profit margin of -184.24%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides